£114.99

Mounjaro® 5mg (Tirzepatide) is a once-weekly prescription injection containing tirzepatide, an innovative dual GIP and GLP-1 receptor agonist. The 5mg dose is commonly prescribed after the initial 2.5mg starting phase and forms part of a structured weight management and metabolic health programme under medical supervision.